Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Alimera Sciences Inc (NQ: ALIM )

2.900 +0.200 (+7.41%)
Streaming Delayed Price Updated: 2:12 PM EST, Feb 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,114
Open 2.760
Bid (Size) 2.830 (1)
Ask (Size) 2.900 (2)
Prev. Close 2.700
Today's Range 2.760 - 2.900
52wk Range 2.030 - 7.920
Shares Outstanding 7,008,482
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Looking Into Alimera Sciences's Return On Capital Employed
 
Via Benzinga
7 Stocks That Could Implode at Any Moment
Although it’s a party-pooper topic, the vagaries of the market dictates that investors should be aware of these stocks to sell. 
Via InvestorPlace

Performance

YTD
-3.01%
-3.01%
1 Month
-3.01%
-3.01%
3 Month
-44.76%
-44.76%
6 Month
-53.97%
-53.97%
1 Year
-35.84%
-35.84%

More News

Read More
Alimera Sciences: Q2 Earnings Insights
Via Benzinga
Recap: Alimera Sciences Q1 Earnings
Via Benzinga
36 of the Best Ideas Companies to Present at the 2nd Annual Winter Wonderland Virtual Investor Conference on February 8th - 11th, 2022
From MicroCap Rodeo
Via AccessWire
2 Moonshots That Insiders Are Buying… and 3 They’re Not
Via InvestorPlace
64 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
3 Penny Stocks Insiders Are Buying
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
92 Biggest Movers From Friday
Via Benzinga
64 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Alimera Sciences, inc (ALIM) Q3 2021 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
Via Benzinga
Exposures Product Safety
Alimera Sciences, inc (ALIM) Q2 2021 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Recap: Alimera Sciences Q2 Earnings
Via Benzinga
60 Biggest Movers From Yesterday
Via Benzinga
Earnings Scheduled For August 13, 2021
Via Benzinga
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
Via Benzinga
Exposures Product Safety
How Does Alimera Sciences's Debt Look?
Via Benzinga
35 of the Best Ideas Companies to Present at the Summer Solstice - Best Ideas from the Buy-Side Virtual Investor Conference on June 1-4, 2021
From MicroCap Rodeo
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.